Laboratory of Bacteriology and Virology of Aristide Le Dantec University Hospital, Dakar, Senegal.
Present Address: IRESSEF: Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formations, Arrondissement 4 Rue 2 D1, Pole Urbain de Diamniado, 7325, Dakar, BP, Senegal.
BMC Infect Dis. 2018 Nov 20;18(1):588. doi: 10.1186/s12879-018-3504-z.
With the expansion of Prevention of Mother to Child Transmission (PMTCT) services in Senegal, there is growing interest in using PMTCT program data in lieu of conducting unlinked anonymous testing (UAT)-based ANC Sentinel Surveillance. For this reason, an evaluation was conducted in 2011-2012 to identify the gaps that need to be addressed while transitioning to using PMTCT program data for surveillance.
We conducted analyses to assess HIV prevalence rates and agreements between Sentinel Surveillance and PMTCT HIV test results. Also, a data quality assessment of the PMTCT program registers and data was conducted during the Sentinel Surveillance period (December 2011 to March 2012) and 3 months prior. Finally, we also assessed selection bias, which was the percentage difference from the HIV prevalence among all women enrolled in the antenatal clinic and the HIV prevalence among women who accepted PMTCT HIV testing.
The median site HIV prevalence using routine PMTCT HIV testing data was 1.1% (IQR: 1.0) while the median site prevalence from the UAT HIV Sentinel Surveillance data was at 1.0% (IQR: 1.6). The Positive per cent agreement (PPA) of the PMTCT HIV test results compared to those of the Sentinel Surveillance was 85.1% (95% CI 77.2-90.7%), and the percent-negative agreement (PNA) was 99.9% (95% CI 99.8-99.9%). The overall HIV prevalence according to UAT was the same as that found for women accepting a PMTCT HIV test and those who refused, with percent bias at 0.00%. For several key PMTCT variables, including "HIV test offered" (85.2%), "HIV test acceptance" (78.0%), or "HIV test done" (58.8%), the proportion of records in registers with combined complete and valid data was below the WHO benchmark of 90%.
The PPA of 85.1 was below the WHO benchmarks of 96.6%, while the combined data validity and completeness rates was below the WHO benchmark of 90% for many key PMTCT variables. These results suggested that Senegal will need to reinforce the quality of onsite HIV testing and improve program data collection practices in preparation for using PMTCT data for surveillance purposes.
随着塞内加尔预防母婴传播(PMTCT)服务的扩大,越来越有兴趣使用 PMTCT 项目数据替代基于未关联匿名检测(UAT)的 ANC 哨点监测。出于这个原因,在 2011-2012 年进行了一项评估,以确定在过渡到使用 PMTCT 项目数据进行监测时需要解决的差距。
我们进行了分析,以评估 HIV 流行率以及哨点监测和 PMTCT HIV 检测结果之间的一致性。此外,在哨点监测期间(2011 年 12 月至 2012 年 3 月)和之前的 3 个月,我们还对 PMTCT 项目登记册和数据进行了数据质量评估。最后,我们还评估了选择偏差,即接受 PMTCT HIV 检测的妇女的 HIV 流行率与所有参加产前诊所的妇女的 HIV 流行率之间的百分比差异。
使用常规 PMTCT HIV 检测数据的中位数站点 HIV 流行率为 1.1%(IQR:1.0),而 UAT HIV 哨点监测数据的中位数站点流行率为 1.0%(IQR:1.6)。PMTCT HIV 检测结果与哨点监测结果的阳性百分比一致性(PPA)为 85.1%(95%CI 77.2-90.7%),阴性百分比一致性(PNA)为 99.9%(95%CI 99.8-99.9%)。根据 UAT,总体 HIV 流行率与接受 PMTCT HIV 检测和拒绝检测的妇女相同,偏差百分比为 0.00%。对于几个关键的 PMTCT 变量,包括“提供 HIV 检测”(85.2%)、“接受 HIV 检测”(78.0%)或“进行 HIV 检测”(58.8%),记录在登记册中的比例完全符合数据完整性标准,低于世卫组织规定的 90%。
PPA 为 85.1%,低于世卫组织规定的 96.6%,而对于许多关键的 PMTCT 变量,组合数据的有效性和完整性率低于世卫组织规定的 90%。这些结果表明,塞内加尔将需要加强现场 HIV 检测的质量,并改善方案数据收集做法,为使用 PMTCT 数据进行监测做好准备。